Teva Pharmaceuticals (TEVA) announces a $3B share repurchase program, expected to be completed...

|About: Teva Pharmaceutical Indus... (TEVA)|By:, SA News Editor

Teva Pharmaceuticals (TEVA) announces a $3B share repurchase program, expected to be completed over a 3-year period. The size of the buyback represents 8% of all outstanding TEVA common stock. Shares +2.1% premarket.